期刊文献+

耐碳青霉烯药物肺炎克雷伯菌研究进展 被引量:10

Research advances on carbapenem-resistant Klebsiella pneumoniae
原文传递
导出
摘要 随着临床碳青霉烯类抗菌药物的大量应用,耐碳青霉烯药物肠杆菌科广泛流行,其中耐碳青霉烯药物肺炎克雷伯菌临床检出率逐渐增加,给临床诊疗和感染控制带来很大挑战。现就耐碳青霉烯肺炎克雷伯菌的感染现状、耐药机制、检测及治疗进展作一综述。 As the clinical application of carbapenem antibiotics, earbapenem-resistant Enterobacteriaceae are widespread, the clinical isolation rate of the carbapenem-resistant Klebsiella pneumoniae increases significantly, which takes a lot of challenges to the clinical treatment and infection control. The article reviews the status of infection, the resistance mechanism,infection detection and treatment progress of carbapencm-resistant KlebsieUa p ne umoniae .
出处 《国际流行病学传染病学杂志》 CAS 2017年第4期282-284,共3页 International Journal of Epidemiology and Infectious Disease
关键词 克雷伯菌 肺炎 碳青霉烯酶 感染 检测 临床治疗 Klebsiella pneumoniae Carbapenemase Infection Detection Clinical treatment
  • 相关文献

参考文献3

二级参考文献39

  • 1刘志远,许淑珍,马纪平,张正,王贺,杜小玲,王清涛,董云秋,赵敏.肠球菌氨基糖苷类高水平耐药基因的检测[J].中华检验医学杂志,2005,28(1):96-99. 被引量:9
  • 2瞿婷婷,杜小幸,陈亚岗,俞云松,李兰娟.氨基苷类高水平耐药肠球菌的耐药性及修饰酶基因分布[J].中国感染与化疗杂志,2006,6(3):163-167. 被引量:12
  • 3童乐艳,马立艳,许淑珍.屎肠球菌对氨苄西林耐药pbp5基因突变的研究[J].中华检验医学杂志,2006,29(8):733-735. 被引量:7
  • 4汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 5Zhu JM, Jiang R J, MI ZH, et al. Novel KPC Variant from a Carbapenem-Resistant Strain of Klebsiella pneumoniae in a Chinese Hospital[J]. Infect Control Hosp Epidemiol, 2011, 32(10):1050-1052.
  • 6Hirseh EB, Tam VH. Detection and treatment options for Klebsiella pneumonia earbapenemases (KPCs): an emerging cause of multidrug-resistant infection [J]. J Antimicrob Chemother, 2010,65(6) :1119- 1125.
  • 7Endimiani A, Patel G, Hujer KM, et al. In vitro activity of fosfomyein against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsuseeptible to tigeeycline and/or colistin [J]. Antimicrob Agents Chemother, 2010,54 ( 1 ) : 526- 529.
  • 8Ruzin A, Visalli MA, Keeney D, et al. Influence of transcriptional activator RamA on expression of muhidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumonia [J]. Antimicrob Agents Chemother, 2005,49(3): 1017- 1022.
  • 9Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens [J]. Antimicrob Agents Chemother, 2012,56(4) :2108-2113.
  • 10Falagas ME, Karageorgopoulos DE, Nordmann P. Therapeutic options for infections with Enterobacteriaceacproducing carbapenem-hydrolyzing enzymes[J]. Future Microbiol, 2011,6(6) :653-666.

共引文献67

同被引文献82

引证文献10

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部